This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Lacrimal Devices Market

Market Insights on Lacrimal Devices covering sales outlook, demand forecast & up-to-date key trends

Lacrimal Devices Market By Product (Monocanalicular Lacrimal Duct Stent Tube and Bicanalicular Lacrimal Duct Stent Tube), End User (Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers) & Region - Forecast 2022 - 2029

Lacrimal Devices Market Snapshot (2022-2029)

[173 Pages Report] From 2022 through 2029, global demand for medical Lacrimal Devices is predicted to expand at a 5.5% compound annual growth rate (CAGR), with a market value of roughly US$ 25.6 million in 2021.

Market Outlook:

Data Points

Market Insights

Market Value 2021

US$ 25.6 Mn

Market Value 2022

US$ 27.3 Mn

Market Value 2029

US$ 39.7 Mn

CAGR 2022-2029

5.5%

Market Share of Top 5 Countries

80%

Lacrimal devices like Nasolacrimal stents are small tubes which establishes a new channel for tears to drain. When the usual tear ducts fail and alternative drainage mechanisms are unavailable, they provide a bypass path for tear drainage. Graue employed the first described stent, which was constructed of silver wire and used in 1932.

Since then, numerous materials such as silk, nylon, polyethylene, and polypropylene have been employed. The tubes are usually made of silicone or another semi-rigid yet flexible material with an open centre lumen.

The increased demand for ophthalmic treatments with greater success rates and minimum intrusions, as well as an increase in patients with nasolacrimal duct obstruction, are driving the worldwide lacrimal devices market.

During the projected period, the introduction of innovative and high-success-rate treatments will move the market forward. Adoption of precise and updated lacrimal devices, such as the new lacrimal cannula, which combines flexibility and strength to prevent trauma by providing easy access to the canaliculus, is a fundamental driver of market expansion.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

5.83%

H1, 2022 Projected

5.83%

H1, 2022 Outlook

5.83%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 45 ↓

A comparative analysis about the market growth rates and development prospects in the global lacrimal devices market has been presented by FMI. The market is subject to be influenced by device regulations and rate of procedure adoption in accordance, with impact of macro and industry factors. The development and launch of the E>Eye IRPL® Treatment device is a major progress in this market.

As per the analysis by Future Market Insights, the market is expected to show a dip in Basis Point Share (BPS) by 45 BPS units in H1-2022 (O) when compared with H1-2021. Major reasons for this decrease in BPS are attributed to the advent of the COVID-19 pandemic and subsequent proliferation of infectious agents, and the side effects associated with surgical incorporation of lacrimal devices.

The variation between the BPS values observed in the lacrimal devices market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS.

Furthermore, due to a restricted number of manufacturers for lacrimal devices, there is a limited product availability, as well as lower awareness regarding device functionality. These factors are thus responsible for the subsequent reduction in the BPS value for the lacrimal devices market.

Lacrimal Devices Sales Analysis From 2014 To 2021 Vs. Market Outlook For 2022 To 2029

The lacrimal devices market holds less than 1% in overall ophthalmic device market which is valued at 50.85 Bn in 2021 and projected to grow in forecast periods.

Over the last few years, medical and technological advancements have accelerated dramatically. The technological advancements are advantageous over traditional method in different perspectives.

In the traditional method such as dacryocystorhinostomy, the subarachnoid area is inadvertently accessed in, problems such as cutaneous scarring, harm to medial canthal structures, haemorrhage, infection, and cerebrospinal fluid rhinorrhoea have been reported.

In comparison to the traditional approach, the lacrimal devices offers a variety of advantages to patients, including improved minor incisions during surgery, more precision, lower infection risks, better patient outcomes with less healing time, and a longer lifespan.

The most frequent lacrimal system disease is nasolacrimal duct blockage. According to the article "Nasolacrimal Duct Obstruction" from 2020, published by NCBI, roughly 6 percent to 20% of babies suffer from various symptoms of nasolacrimal duct obstruction along with punctal agenesis or congenital fistulas.

Congenital nasolacrimal duct obstruction has a high incidence of spontaneous resolution, with roughly 70% of affected children free of symptoms by 3 months of age and over 90% recovering by their first birthday. Infants with trisomy 21, ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome, branchiooculofacial syndrome, CHARGE (coloboma, heart anomaly, choanal atresia, and retardation, genital and ear abnormalities) syndrome, and Goldenhar syndrome are at a higher risk for this disorder.

As a result, market growth is likely to be driven by the increased prevalence of such health disorders over the forecast period.

Bicanalicular lacrimal devices remain the most popular, because of its ease of use, increased patient compliance, material compatibility, and better clinical outcomes. Bicanalicular lacrimal devices account for maximum shares of global market value, and this trend is expected to continue through 2029.

Lacrimal Devices Market Download Report Brochure

The market is expected to expand at a considerable growth rate over the next seven years at a CAGR of close to 5.5%.

What Are The Key Opportunities For Lacrimal Devices Market?

The lacrimal devices are more effective and is a minimal invasive procedure for the management of the lacrimal duct obstruction expected to generate more revenue generation opportunity with due to enhanced product efficacy. Increased awareness of the availability of Lacrimal Devices, as well as subsequent adoption, is predicted to produce significant income.

Improved adoption of devices for nasolacrimal duct obstruction management is predicted to be aided by increased awareness of their availability and efficacy among healthcare practitioners. There are many different types of Lacrimal Devices on the market, which means there's a lot of money to be made.

Because of the restricted number of producers and thus limited product availability, there is a significant unmet demand in the efficient management of lacrimal duct obstruction in both developing and developed countries.

According to research studies published in NCBI, the prevalence of nasolacrimal duct blockage disease is projected to rise dramatically as the number of new-borns each year rises. Furthermore, the DCR procedure's one-time treatment strategy reflects superior management of lacrimal duct occlusion.

As a result of these advancements, the lacrimal devices market is expected to be profitable over the forecast period.

What Are The Factors Restraining Demand For Lacrimal Devices?

Several complications such as corneal abrasion, canaliculitis, prolapse, and others can develop after a dacryocystorhinostomy (DCR) operation. Stent tubes in the lacrimal duct can become dislodged and travel via the lacrimal duct to the eye or nasal cavity, causing discomfort and, in rare cases, false channel construction during intubation, or cheese wiring of the punctum.

Despite the fact that producers in the lacrimal devices market are fixing problems by changing the length, manufacturing material, and other factors, the method still poses a risk of difficulties, especially given the age range for which stenting is performed. These problems may limit the market's future expansion.

The majority of lacrimal devices manufacturers are based in developed regions such as North America and Europe. Latin America, East and South Asia, and other developing nations frequently rely on western manufacturers. As a result, product availability is constrained in a number of high-revenue-potential locations, stifling market expansion.

Manufacturers who do not have a regional production plant rely on multiple regional or country-level distributors to get their goods into the market. It frequently leads to increased product costs and limited availability. Despite the fact that manufacturers are eager to expand their regional product footprints, their efforts are still limited.

The evaluation of lacrimal devices safety is an important part of the development process, which can be challenging. The market for lacrimal devices is hampered by the problems described above.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-Wise Insights

What makes the U.S. the largest market for lacrimal Devices?

The U.S. dominates the North American region with a total market share of over 95.9% in 2021, and is projected to continue experiencing high growth throughout the forecast period.

U.S. is expected to have the biggest market share over the research period, because of its strong medical industry and high healthcare spending, The need for lacrimal devices is increasing due to advanced and contemporary medical and ophthalmology facilities, as well as a significant increase in lacrimal disorders.

The regional market is growing because of rising per ca-pita healthcare spending and favourable government initiatives for integrated healthcare systems in U.S. Furthermore, the growing number of individuals with retinal illnesses provides more chances for market participants.

Why Germany is considered a lucrative market for lacrimal devices in Europe?

Germany has a higher CAGR of 6.2% in the European medical lacrimal devices market during the forecast period and holds a majority share of 33.5% in 2021. This is majorly due to its improved regulatory environment for surgical devices and increased awareness among the population for such treatments in lacrimal duct obstruction and related health concerns. To efficiently serve their patients, industry companies have well-established direct channel collaborations with hospitals and ophthalmic clinics. Furthermore, the corporations have planned acquisitions with well-known clinics and hospitals in order to extend their business operations in the United Kingdom.

What makes China an emerging market for lacrimal devices?

China is projected to increase at a CAGR rate of 6.5% during the forecast period. China maintains a significant contributor to global market value, thanks to increase per capita healthcare spending and several government programmes for integrated healthcare systems in the region.

What makes Japan an emerging market for lacrimal devices?

Japanese lacrimal device market is projected to increase at a CAGR 6.3% during forecast period and holds a majority share of 81.1% in the East Asian market due its well-developed manufacturing capacity and supply chain globally.

What makes India an emerging market for lacrimal devices?

Indian lacrimal devices market is expected to grow from US$ 0.42 Mn in 2021 to US$ 0.67 Mn by 2029 end. This represents CAGR of 5.8% over the opportunity assessment period. This is attributable to improved surgical device regulations and increased public knowledge of the need for such procedures in the event of lacrimal duct obstruction and other related disorders.

Category-Wise Insights

Which lacrimal devices product is driving market growth?

The global lacrimal devices market is dominated by bicanalicular lacrimal duct stent tubes with total market share of over 74.5% in 2021. . Two probes with an intermediate stent are used in bicanalicular lacrimal tubes. For children with nasolacrimal duct obstruction, bicanalicular lacrimal intubation is an effective treatment, and the younger the children are, the better the success rate.

Easier use, higher patient compliance, and the material compatibility of the bicanalicular lacrimal duct stent with the patient without producing any adverse reactions are all major factors in the segment's growth.

Which end user benefits the most by employment of lacrimal devices?

In terms of revenue, hospitals with total market share of over 48.7% led the global lacrimal devices market, and this trend is expected to continue during the opportunity assessment period. Hospitals are predicted to be the most profitable segment as hospitals provides maximum availability of device to patients who visit these facilities for the treatment purpose.

In terms of revenue, which region is projected to lead the Lacrimal Devices market?

North America continues to be the most profitable region in terms of revenue with total market share of over 47.2% in 2021 and it is expected to increase at a rapid pace during the projected period.

What is the Impact of COVID-19 on the Lacrimal Devices Industry?

The COVID-19 pandemic originally had a restrictive impact on growth of lacrimal devices market. This impact was registered principally due to the guidelines published by different regulatory bodies, advising that patients getting treatment for non-urgent medical issues are at a greater risk of spreading of COVID-19 infections.

The rise in the prevalence of infectious diseases, chronic diseases and the increasing disease burden over the globe due to the COVID-19 pandemic led to advancements in digital solutions as well as automated testing solutions.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

Leading lacrimal device manufacturers are focusing on geographic growth in order to increase revenue and expand their sales presence in emerging markets by acquiring local market players.

Manufacturers use strategic alliances, acquisitions, expansion, new launches, agreements, and research sponsorship as essential tactics to improve product sales in various geographies. With regional and worldwide competitors, the Lacrimal Devices market is moderately competitive.

FCI Ophthalmics, Kaneka Medical America LLC, Gunther Weiss Scientific Glassblowing, and Bess Medizintechnik GmBH are some of the global market participants. The key companies are pursuing various growth strategies such as acquisitions, product innovation, and expansion, all of which are contributing to the global growth of the Lacrimal Devices market.

  • FCI Ophthalmics, Inc. released LacriJet in the United States in July 2021. It's the first monocanalicular nasolacrimal intubation with self-retention preloaded on a single-use injector. The LacriJet system is made up of a single-use injector handpiece with a silicone tube preloaded inside a metallic probe. LacriJet was created with the goal of reducing operating time during intubation and device removal. Epiphora, congenital nasolacrimal duct obstruction (CNLDO), and canalicular laceration are among the conditions for which it is prescribed.
  • Precivia, or the Precision Intravitreal Injection Assistant, is FCI's gold standard for all intravitreal injections, and it is available from September 14, 2020. Its unique design ensures a safe and accurate procedure by fixing the injection angle, position, and depth. Precivia also does away with the necessity for a speculum, calliper, marker, and pressure plate.
  • A number of organisations are working on developing innovative Lacrimal Devices products. In June 2019, FCI Ophthalmic launched a full line of BIKA stents, including BIKA, BIKA for DCR, and Infant BIKA, in a variety of diameters to benefit the majority of congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) patients.

Similarly, the Future Market Insights team has kept track of recent developments involving firms that manufacture Lacrimal Devices goods, which are detailed in the complete research.

Report Scope As Per Lacrimal Devices Industry Analysis

Attribute

Details

Forecast Period

2022-2029

Historical Data Available for

2014-2021

Market Analysis

Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Turkey and South Africa

Key Market Segments Covered

Product, End User and Region

Key Companies Profiled

FCI Ophthalmics

Kaneka Corporation (Kaneka Pharma America LLC)

Gunther Weiss Scientific Glass

Bess Medizintechnik GmBH

Pricing

Available upon Request

Key Market Segments Covered In Lacrimal Devices Industry Research

By Product:

  • Monocanalicular Lacrimal Duct Stent Tube
  • Bicanalicular Lacrimal Duct Stent Tube

By End User:

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The lacrimal devices market is expected to reach US$ 39.7 Mn by the end of 2029, with sales revenue expected to register 5.5% CAGR with present market value of

The U.S., Germany, France, Japan and China re expected to drive demand in Lacrimal Devices market.

By product, bicanalicular lacrimal devices emerged as the most appealing segment, accounting for 3/4 of the revenue share in the lacrimal devices market.

The prominent participants in the Lacrimal Devices market are FCI Ophthalmics and Kaneka Corporation. These companies' primary goal is to produce new products. Manufacturers compete on additional parameters such as good marketing strategy among ophthalmologists and cost effectiveness.

FCI Ophthalmics, Kaneka Corporation (Kaneka Pharma America LLC), Gunther Weiss Scientific Glass, Bess Medizintechnik GmBH are the key exporters of lacrimal devices market.

The lacrimal devices market was around US$ 25.6 Mn in 2021, with sales revenue registering growth of 5.2% CAGR between 2014 and 2021.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Key Success Factors

    4.1. Global Lacrimal Devices Market : Pricing Analysis

    4.2. Epidemiology of Nasolacrimal Duct Obstruction ( with Treatment Seeking Rate & Untreated Population)

5. Global Lacrimal Devices Market - Pricing Analysis

    5.1. Regional Pricing Analysis By Product 

    5.2. Global Average Pricing Analysis Benchmark

6. Global Lacrimal Devices Market Value (US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029

    6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Market Background

    7.1. Macro-Economic Factors

    7.2. Forecast Factors - Relevance & Impact

    7.3. Market Dynamics

        7.3.1. Drivers

        7.3.2. Restraints

        7.3.3. Opportunity Analysis

8. Global Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029, by Product 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) & Volume Analysis By Product, 2014–2021

    8.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product, 2022-2029

        8.3.1. Monocanalicular Lacrimal Duct Stent Tube

        8.3.2. Bicanalicular Lacrimal Duct Stent Tube     

    8.4. Market Attractiveness Analysis By Product

9. Global Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029, by End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2029

        9.3.1. Hospitals

        9.3.2. Ophthalmic Clinics

        9.3.3. Ambulatory Surgical Centers

    9.4. Market Attractiveness Analysis By End User

10. Global Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029, by Region

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    11.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Product

        11.3.3. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Product

        11.4.3. By End User

    11.5. Drivers and Restraints - Impact Analysis

12. Latin America Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    12.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Product

        12.3.3. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product

        12.4.3. By End User

    12.5. Drivers and Restraints - Impact Analysis

13. Europe Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    13.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Product

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By End User

    13.5. Drivers and Restraints - Impact Analysis

14. South Asia Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    14.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Product

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By End User

    14.5. Drivers and Restraints - Impact Analysis

15. East Asia Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    15.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Product

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By End User

    15.5. Drivers and Restraints - Impact Analysis

16. Oceania Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    16.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Product

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By End User

    16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Lacrimal Devices Market Analysis 2014-2021 and Forecast 2022-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2021

    17.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Market Taxonomy, 2022-2029

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Turkey

            17.3.1.3. Northern Africa

            17.3.1.4. South Africa

            17.3.1.5. Rest of Middle East and Africa

        17.3.2. By Product

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By End User

    17.5. Drivers and Restraints - Impact Analysis

18. Emerging Countries Lacrimal Devices Market Analysis 2022 & 2029

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. China Lacrimal Devices Market Analysis

        18.2.1. Introduction

        18.2.2. PEST Analysis

        18.2.3. Market Value Analysis by Market Taxonomy

        18.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.2.4.1. By Product

            18.2.4.2. By End User

    18.3. India Lacrimal Devices Market Analysis

        18.3.1. Introduction

        18.3.2. PEST Analysis

        18.3.3. Market Value Analysis by Market Taxonomy

        18.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.3.4.1. By Product

            18.3.4.2. By End User

    18.4. Brazil Lacrimal Devices Market Analysis

        18.4.1. Introduction

        18.4.2. PEST Analysis

        18.4.3. Market Value Analysis by Market Taxonomy

        18.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.4.4.1. By Product

            18.4.4.2. By End User

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. FCI Ophthalmics

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Profitability by Market Segments(Product/Channel/Region)

            19.3.1.4. Sales Footprint

            19.3.1.5. Strategy Overview

                19.3.1.5.1. Marketing Strategy

                19.3.1.5.2. Product Strategy

                19.3.1.5.3. Channel Strategy

        19.3.2. Kaneka Pharma America LLC

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Profitability by Market Segments(Product/Channel/Region)

            19.3.2.4. Sales Footprint

            19.3.2.5. Strategy Overview

                19.3.2.5.1. Marketing Strategy

                19.3.2.5.2. Product Strategy

                19.3.2.5.3. Channel Strategy

        19.3.3. Gunther Weiss Scientific Glass

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Profitability by Market Segments(Product/Channel/Region)

            19.3.3.4. Sales Footprint

            19.3.3.5. Strategy Overview

                19.3.3.5.1. Marketing Strategy

                19.3.3.5.2. Product Strategy

                19.3.3.5.3. Channel Strategy

        19.3.4. Bess Medizintechnik Gmbh

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Profitability by Market Segments(Product/Channel/Region)

            19.3.4.4. Sales Footprint

            19.3.4.5. Strategy Overview

                19.3.4.5.1. Marketing Strategy

                19.3.4.5.2. Product Strategy

                19.3.4.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 02: Global Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 03: Global Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 04: Global Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region

Table 05: North America Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 06: North America Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 07: North America Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 08: North America Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 09: Latin America Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 10: Latin America Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 11: Latin America Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 12: Latin America Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 13: Europe Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 14: Europe Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 15: Europe Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 16: Europe Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 17: South Asia Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 18: South Asia Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 19: South Asia Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 20: South Asia Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 21: East Asia Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 22: East Asia Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 23: East Asia Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 24: East Asia Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 25: Oceania Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 26: Oceania Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 27: Oceania Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 28: Oceania Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 29: MEA Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 30: MEA Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 31: MEA Lacrimal Duct Stent Tube Volume (000’ Units) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 32: MEA Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 33: China Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 34: China Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 35: India Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 36: India Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Table 37: Brazil Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 38: Brazil Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Lacrimal Duct Stent Tube Historical Market Volume (000’ Units) and Y-o-Y, 2014-2021

Figure 02: Global Lacrimal Devices Market Volume (000’ Units) & Y-o-Y Growth (%), 2022–2029

Figure 03: Monocanalicular Lacrimal Duct Stent Tube Pricing Analysis  (US$) By Region, 2021 (Per Unit)

Figure 04: Bicanalicular Lacrimal Duct Stent Tube Pricing Analysis  (US$) By Region, 2021 (Per Unit)

Figure 05: Global Lacrimal Duct Stent Tube Historical Market Size and Y-o-Y, 2014-2021

Figure 06: Global Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029

Figure 07: Global Lacrimal Devices Market Absolute $ Opportunity, 2014–2029

Figure 08: Global Lacrimal Devices Market Analysis by Product –2022 & 2029

Figure 09: Global Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 10: Global Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Figure 11: Global Lacrimal Devices Market Analysis by End User –2022 & 2029

Figure 12: Global Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 13: Global Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By End User

Figure 14: Global Lacrimal Devices Market Analysis by Region –2022 & 2029

Figure 15: Global Lacrimal Devices Market Y-o-Y Growth Projections by Region, 2022 – 2029

Figure 16: Global Lacrimal Devices Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region

Figure 17: North America Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 18: North America Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 19: North America Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 20: North America Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 21: North America Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 22: North America Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 23: North America Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 24: North America Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 25: : North America Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 26: North America Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 27: North America Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 28: Latin America Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 29: Latin America Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 30: Latin America Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 31: Latin America Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 32: Latin America Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 33: Latin America Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 34: Latin America Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 35: Latin America Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 36: Latin America Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 37: Latin America Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 38: Latin America Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 39: Europe Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 40: Europe Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 41: Europe Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 42: Europe Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 43: Europe Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 44: Europe Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 45: Europe Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 46: Europe Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 47: Europe Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 48: Europe Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 49: Europe Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 50: South Asia Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 51: South Asia Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 52: South Asia Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 53: South Asia Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 54: South Asia Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 55: South Asia Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 56: South Asia Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 57: South Asia Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 58: South Asia Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 59: South Asia Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 60: South Asia Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 61: East Asia Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 62: East Asia Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 63: East Asia Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 64: East Asia Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 65: East Asia Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 66: East Asia Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 67: East Asia Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 68: East Asia Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 69: East Asia Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 70: East Asia Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 71: East Asia Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 72: Oceania Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 73: Oceania Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 74: Oceania Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 75: Oceania Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 76: Oceania Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 77: Oceania Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 78: Oceania Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 79: Oceania Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 80: Oceania Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 81: Oceania Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 82: Oceania Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 83: MEA Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 84: MEA Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 85: MEA Lacrimal Devices Market Analysis by Country –2022 & 2029

Figure 86: MEA Lacrimal Devices Market Y-o-Y Growth Projections by Country, 2022 – 2029

Figure 87: MEA Lacrimal Devices Market Attractiveness Analysis by Country, 2022 – 2029

Figure 88: MEA Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 89: MEA Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 90: MEA Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 91: MEA Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 92: MEA Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 93: MEA Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 94: Emerging Countries Market Value Share (2022 E) 

Figure 95: Emerging Countries Lacrimal Devices Market Value (US$ Mn), By Key Countries, 2014-2029

Figure 96: China Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 97: China Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 98: China Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 99: China Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 100: China Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 101: China Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 102: China Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 103: China Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 104: India Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 105: India Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 106: India Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 107: India Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 108: India Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 109: India Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 110: India Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 111: India Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Figure 112: Brazil Lacrimal Devices Market Size (US$ Mn) Analysis, 2014–2021

Figure 113: Brazil Lacrimal Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 114: Brazil Lacrimal Devices Market Analysis by Product–2022 & 2029

Figure 115: Brazil Lacrimal Devices Market Y-o-Y Growth Projections by Product, 2022 – 2029

Figure 116: Brazil Lacrimal Devices Market Attractiveness Analysis by Product, 2022 – 2029

Figure 117: Brazil Lacrimal Devices Market Analysis by End User – 2022 & 2029

Figure 118: Brazil Lacrimal Devices Market Y-o-Y Growth Projections by End User, 2022 – 2029

Figure 119: Brazil Lacrimal Devices Market Attractiveness Analysis by End User, 2022 – 2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Ophthalmic Eye Drops Market

Published : May 2021

Healthcare

Lacrimal Devices Market

Published : January 2020

Healthcare

Eye Infections Treatment Market

Published : February 2022

Healthcare

Cardiac Assist Devices Market

Published : August 2021

Google translate

Lacrimal Devices Market